Connect Sign InBiomarkers and Actionable Gene Mutations in Gastrointestinal Cancer
Dr. Matkowskyj will review the role and repertoire of current biomarkers in gastrointestinal cancers including actionable mutations and alterations. She will provide real world examples of current biomarkers and their impact on clinical outcomes. Dr. Matkowskyj will share her personal experience with a recently approved companion diagnostic biomarker and conclude her talk with emerging biomarkers in the gastric cancer space.
Dr. Matkowskyj attended the University of Illinois in Chicago for her graduate and medical school degrees and then completed her anatomic pathology residency and GI/liver pathology fellowship at Northwestern University/McGaw Medical Center in Chicago. She is a board-certified anatomic pathologist, who practiced at the University of Wisconsin-Madison for 12 years. She recently relocated and is a professor in the Department of Laboratory Medicine at Mayo Clinic in Rochester, Minnesota. She serves on several NIH review panels, and is a member of the CAP Cancer Committee and the Gastric HER2 Guidelines Panel. She previously served as a member of the NCCN Guideline panels for esophageal and gastric cancers. Dr. Matkowskyj’s research focuses on novel biomarkers and experimental therapeutics in gastrointestinal and pancreaticobiliary malignancies.
